Precision Biosensor Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,291	1,723	2,426	7,557	5,544
Short-Term Investments	7,136	2,095	4,090	1,093	17,140
Cash & Short-Term Investments	10,427	3,818	6,517	8,650	22,683
Cash Growth	173.11%	-41.41%	-24.66%	-61.87%	-5.38%
Accounts Receivable	1,998	1,735	1,821	1,657	2,305
Other Receivables	443.9	683.29	646.08	332.68	439.78
Receivables	2,885	3,109	2,467	1,989	2,745
Inventory	8,874	8,994	9,234	9,639	7,524
Prepaid Expenses	158.87	107.21	108.06	155.74	212.39
Other Current Assets	223.88	342.33	118.9	336.03	130.72
Total Current Assets	22,569	16,371	18,445	20,771	33,295
Property, Plant & Equipment	26,445	30,836	33,469	27,806	15,490
Long-Term Investments	1,500	1,500	5,000	5,000	5,000
Other Intangible Assets	1,898	2,676	3,225	3,759	24.16
Long-Term Deferred Tax Assets	-	-	477.37	370.25	164
Other Long-Term Assets	662.35	656.59	1,171	612.62	1,746
Total Assets	53,074	52,039	62,478	59,010	55,718
Accounts Payable	700.8	545.06	430.28	769.13	902.86
Accrued Expenses	1,146	1,172	979.08	585.07	680.54
Short-Term Debt	4,383	5,962	4,644	8,113	-
Current Portion of Long-Term Debt	7,500	6,000	3,000	3,000	-
Current Portion of Leases	691.72	746.6	703.94	725.23	104.41
Current Unearned Revenue	26.09	-	-	-	-
Other Current Liabilities	3,135	4,966	3,588	6,849	463.86
Total Current Liabilities	17,583	19,391	13,345	20,041	2,152
Long-Term Debt	1,500	4,375	10,786	3,000	9,325
Long-Term Leases	549.24	579.31	1,165	1,717	222.34
Long-Term Unearned Revenue	21.74	-	-	-	-
Pension & Post-Retirement Benefits	436.37	579.59	593.94	646.15	313.06
Other Long-Term Liabilities	216.98	1,416	4,560	230.17	5,353
Total Liabilities	20,308	26,341	30,451	25,634	17,365
Common Stock	8,979	5,807	5,807	5,796	5,683
Additional Paid-In Capital	72,293	58,301	57,599	54,415	53,224
Retained Earnings	-49,539	-39,561	-32,132	-27,361	-20,699
Comprehensive Income & Other	1,033	1,150	753.8	525.75	145.8
Shareholders' Equity	32,767	25,698	32,027	33,375	38,353
Total Liabilities & Equity	53,074	52,039	62,478	59,010	55,718
Total Debt	14,624	17,663	20,299	16,555	9,652
Net Cash (Debt)	-4,197	-13,845	-13,783	-7,904	13,032
Net Cash Growth	-	-	-	-	-43.30%
Net Cash Per Share	-332.51	-1192.10	-1187.80	-685.77	1154.32
Filing Date Shares Outstanding	15.65	11.61	11.61	11.59	11.37
Total Common Shares Outstanding	15.65	11.61	11.61	11.59	11.37
Working Capital	4,986	-3,021	5,099	729.46	31,143
Book Value Per Share	2093.83	2212.54	2757.53	2879.32	3374.36
Tangible Book Value	30,869	23,021	28,803	29,616	38,329
Tangible Book Value Per Share	1972.55	1982.12	2479.87	2555.06	3372.23
Land	9,037	9,037	9,037	7,542	2,723
Buildings	13,512	14,974	14,953	7,685	7,685
Machinery	13,631	13,973	10,701	10,412	7,655
Construction In Progress	212.25	111.35	2,792	4,793	764

Source: S&P Global Market Intelligence. Standard template. Financial Sources.